CIPLA CIPLA LTD
Healthcare
LTP
1,411
CHG · %
+6.9 (+0.49%)
VOL · TODAY
15.67L
PREV CLOSE
1,404.1
Today's range1,382 · 1,411
1,411
52-week range1,165.7 · 1,539.7
1,411
Loading candles…
Cipla Ltd, incorporated in 1935, operates in the pharmaceutical industry focusing on manufacturing, developing, and marketing a wide range of branded and generic formulations as well as active pharmaceutical ingredients (APIs). The company has a presence in India, South Africa, and the United States. Cipla's core offerings include products in therapeutic areas such as respiratory, anti-infectives, and cardiac care. It holds a leading position in the Indian pharmaceutical market (IPM). The company is engaged globally in providing affordable medicines across various treatment segments.
- Market MoversGap DownStocks opening significantly below the previous close — indicates selling pressure or negative news
- MomentumLong BuildupRise in price with increasing open interest — indicates strong bullish momentum
- BreakoutsDaily BreakoutsStocks breaking above recent resistance — short-term bullish opportunity
This page is a live market overview for CIPLA LTD (CIPLA) on the NSE. As a listed security, CIPLA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CIPLA before placing trades on tick2trade.
As of the latest feed, CIPLA last traded at ₹1,411 on NSE, up ₹6.9 (0.49%) from the previous close of ₹1,404.1. Today's session range is ₹1,382 – ₹1,411, against a 52-week band of ₹1,165.7 – ₹1,539.7. Traded volume today stands at 15.67L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for CIPLA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CIPLA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CIPLA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CIPLA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CIPLA option chain page linked from this overview.
// similar in healthcare326 total